1887

Journal of General Virology header logo

Volume 87, Issue 8

interacts with human platelet glycoprotein VI Free

Abstract

(HCV) interacts with human platelets as a potential transport of infectious virions to the target liver. The binding of native viral particles with the platelet membrane glycoprotein VI (GPVI) was analysed. A consistent interaction between HCV from plasma or after purification by two different methods and the recombinant extracellular immunoglobulin (Ig)-like domains of human GPVI (hD1D2) was observed with two independent experimental approaches: pull-down and ELISA assays. Between 2 and 7 % of HCV particles were specifically bound to hD1D2. The binding was inhibited by an anti-hD1D2 in a dose-dependent manner. Human D1D2 interaction with HCV was significantly higher than the murine D1D2, supporting the specificity of the interaction and to the single human domains (D1 and D2), suggesting that both Ig-like domains of the molecule are required for efficient binding. GPVI may be a platelet surface ligand for HCV playing a role in viral transport and persistence.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81826-0
2006-08-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/8/2243.html?itemId=/content/journal/jgv/10.1099/vir.0.81826-0&mimeType=html&fmt=ahah

References

  1. Agnello V., Abel G., Elfahal M., Knight G. B., Zhang Q. X. 1999; Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 96:12766–12771 [CrossRef]
     [Google Scholar]
  2. Bik T., Sarov I., Livne A. 1982; Interaction between vaccinia virus and human blood platelets. Blood 59:482–487
     [Google Scholar]
  3. Candotti D., Temple J., Sarkodie F., Allain J. P. 2003; Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 77:7914–7923 [CrossRef]
     [Google Scholar]
  4. Chelucci C., Federico M., Guerriero R. & 7 other authors 1998; Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 91:1225–1234
     [Google Scholar]
  5. Clayton R. F., Owsianka A., Aitken J., Graham S., Bhella D., Patel A. H. 2002; Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles. J Virol 76:7672–7682 [CrossRef]
     [Google Scholar]
  6. Clemetson K. J., McGregor J. L., James E., Dechavanne M., Luscher E. F. 1982; Characterization of the platelet membrane glycoprotein abnormalities in Bernard–Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 70:304–311 [CrossRef]
     [Google Scholar]
  7. Clemetson J. M., Polgar J., Magnenat E., Wells T. N., Clemetson K. J. 1999; The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to Fc α R and the natural killer receptors. J Biol Chem 274:29019–29024 [CrossRef]
     [Google Scholar]
  8. de Almeida A. J., Campos-de-Magalhaes M., de Melo Marcal O. P., Brandao-Mello C. E., Okawa M. Y., de Oliveira R. V., do Espirito-Santo M. P., Yoshida C. F., Lampe E. 2004; Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study. Ann Hematol 83:434–440 [CrossRef]
     [Google Scholar]
  9. Floreani A., Biasin M. R., Marchelle G., Graziotto A., Chiaramonte M., Infantolino D. 1996; Are human platelets a site of HCV replication?. Hepatology 24:511A
     [Google Scholar]
  10. Forghani B., Schmidt N. J. 1983; Association of herpes simplex virus with platelets of experimentally infected mice. Arch Virol 76:269–274 [CrossRef]
     [Google Scholar]
  11. Gardner J. P., Durso R. J., Arrigale R. R., Donovan G. P., Maddon P. J., Dragic T., Olson W. C. 2003; L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci U S A 100:4498–4503 [CrossRef]
     [Google Scholar]
  12. Gavrilovskaya I. N., Shepley M., Shaw R., Ginsberg M. H., Mackow E. R. 1998; β 3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A 95:7074–7079 [CrossRef]
     [Google Scholar]
  13. Gomez-Villamandos J. C., Ruiz-Villamor E., Salguero F. J., Bautista M. J., Carrasco L., Sanchez C., Quezada M., Sierra M. A. 1998; Immunohistochemical and ultrastructural evidence of hog cholera virus infection of megakaryocytes in bone marrow and spleen. J Comp Pathol 119:111–119 [CrossRef]
     [Google Scholar]
  14. Griffin H. M., Ouwehand W. H. 1995; A human monoclonal antibody specific for the leucine-33 (P1A1, HPA-1a) form of platelet glycoprotein IIIa from a V gene phage display library. Blood 86:4430–4436
     [Google Scholar]
  15. Hamaia S., Li C., Allain J. P. 2001; The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 98:2293–2300 [CrossRef]
     [Google Scholar]
  16. Ishikawa T., Ichida T., Matsuda Y., Sugitani S., Sugiyama M., Kato T., Miyazaki H., Asakura H. 1998; Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol 13:907–913 [CrossRef]
     [Google Scholar]
  17. Jandrot-Perrus M., Busfield S., Lagrue A. H. & 9 other authors 2000; Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 96:1798–1807
     [Google Scholar]
  18. Korporaal S. J., Relou I. A., van Eck M. & 7 other authors 2004; Binding of low density lipoprotein to platelet apolipoprotein E receptor 2′ results in phosphorylation of p38MAPK. J Biol Chem 279:52526–52534 [CrossRef]
     [Google Scholar]
  19. Lee T. H., Stromberg R. R., Henrard D., Busch M. P. 1993; Effect of platelet-associated virus on assays of HIV-1 in plasma. Science 262:1585–1586
     [Google Scholar]
  20. Lee T. H., Stromberg R. R., Heitman J. W., Sawyer L., Hanson C. V., Busch M. P. 1998; Distribution of HIV type 1 (HIV-1) in blood components: detection and significance of high levels of HIV-1 associated with platelets. Transfusion 38:580–588 [CrossRef]
     [Google Scholar]
  21. Levy S., Todd S. C., Maecker H. T. 1998; CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16:89–109 [CrossRef]
     [Google Scholar]
  22. Li X. M., Jeffers L. J., Shao L. J., De Medina M. 1994; Platelets are carriers of HCV-RNA in patients with HCV infection. Gastroenterology 106:A903
     [Google Scholar]
  23. Lozach P. Y., Lortat-Jacob H., de Lacroix de Lavalette A. & 9 other authors 2003; DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 278:20358–20366 [CrossRef]
     [Google Scholar]
  24. Major M. E., Rehermann B., Feinstone S. M. 2001; Hepatitis C viruses. In Fields Virology , 4th edn. pp  1127–1161 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
     [Google Scholar]
  25. Martin T. G. III, Somberg K. A., Meng Y. G., Cohen R. L., Heid C. A., de Sauvage F. J., Shuman M. A. 1997; Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 127:285–288 [CrossRef]
     [Google Scholar]
  26. Monazahian M., Bohme I., Bonk S., Koch A., Scholz C., Grethe S., Thomssen R. 1999; Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 57:223–229 [CrossRef]
     [Google Scholar]
  27. Montigiani S., Neri G., Neri P., Neri D. 1996; Alanine substitutions in calmodulin-binding peptides result in unexpected affinity enhancement. J Mol Biol 258:6–13 [CrossRef]
     [Google Scholar]
  28. Nagamine T., Ohtuka T., Takehara K., Arai T., Takagi H., Mori M. 1996; Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 24:135–140 [CrossRef]
     [Google Scholar]
  29. Neri D., de Lalla C., Petrul H., Neri P., Winter G. 1995; Calmodulin as a versatile tag for antibody fragments. Biotechnology 13:373–377 [CrossRef]
     [Google Scholar]
  30. Nieswandt B., Watson S. P. 2003; Platelet-collagen interaction: is GPVI the central receptor?. Blood 102:449–461 [CrossRef]
     [Google Scholar]
  31. Olinger G. G., Saifuddin M., Spear G. T. 2000; CD4-negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells. J Virol 74:8550–8557 [CrossRef]
     [Google Scholar]
  32. Osawa M., Kuwamoto S., Izumi Y., Yap K. L., Ikura M., Shibanuma T., Yokokura H., Hidaka H., Matsushima N. 1999; Evidence for calmodulin inter-domain compaction in solution induced by W-7 binding. FEBS Lett 442:173–177 [CrossRef]
     [Google Scholar]
  33. Peck-Radosavljevic M., Zacherl J., Meng Y. G., Pidlich J., Lipinski E., Langle F., Steininger R., Muhlbacher F., Gangl A. 1997; Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?. J Hepatol 27:127–131 [CrossRef]
     [Google Scholar]
  34. Pedreno J., de Castellarnau C., Cullare C., Sanchez J., Gomez-Gerique J., Ordonez-Llanos J., Gonzalez-Sastre F. 1992; LDL binding sites on platelets differ from the “classical” receptor of nucleated cells. Arterioscler Thromb 12:1353–1362 [CrossRef]
     [Google Scholar]
  35. Pileri P., Uematsu Y., Campagnoli S. & 8 other authors 1998; Binding of hepatitis C virus to CD81. Science 282:938–941 [CrossRef]
     [Google Scholar]
  36. Pockros P. J., Duchini A., McMillan R., Nyberg L. M., McHutchison J., Viernes E. 2002; Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol 97:2040–2045 [CrossRef]
     [Google Scholar]
  37. Pohlmann S., Zhang J., Baribaud F. & 7 other authors 2003; Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 77:4070–4080 [CrossRef]
     [Google Scholar]
  38. Pugliese A., Gennero L., Cutufia M., Enrietto M., Morra E., Pescarmona P., Ponzetto A. 2004; HCV infective virions can be carried by human platelets. Cell Biochem Funct 22:353–358 [CrossRef]
     [Google Scholar]
  39. Rhainds D., Brissette L. 2004; The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. Defining the rules for lipid traders. Int J Biochem Cell Biol 36:39–77 [CrossRef]
     [Google Scholar]
  40. Sanjo A., Satoi J., Ohnishi A., Maruno J., Fukata M., Suzuki N. 2003; Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol 18:638–644 [CrossRef]
     [Google Scholar]
  41. Scarselli E., Ansuini H., Cerino R. & 7 other authors 2002; The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21:5017–5025 [CrossRef]
     [Google Scholar]
  42. Silva M., Li X., Cheinquer H. & 10 other authors 1992; HCV associated idiopathic thrombocytopenic purpura (ITP). Gastroenterology 102:A889
     [Google Scholar]
  43. Smethurst P. A., Joutsi-Korhonen L., O'Connor M. N. & 12 other authors 2004; Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody. Blood 103:903–911
     [Google Scholar]
  44. Takehara K., Otsuka T., Arai T., Matsuzaki Y., Sato K., Moriguchi M., Takagi H., Nagamine T. 1994; Detection of hepatitis C virus (HCV) in platelets of type C chronic liver diseases by polymerase chain reaction (PCR). Gastroenterology 106:A995
     [Google Scholar]
  45. van Kooyk Y., Geijtenbeek T. B. 2003; DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3:697–709 [CrossRef]
     [Google Scholar]
  46. Wang S., He R., Patarapotikul J., Innis B. L., Anderson R. 1995; Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 213:254–257 [CrossRef]
     [Google Scholar]
  47. Wellnitz S., Klumpp B., Barth H., Ito S., Depla E., Dubuisson J., Blum H. E., Baumert T. F. 2002; Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines. J Virol 76:1181–1193 [CrossRef]
     [Google Scholar]
  48. Wunschmann S., Medh J. D., Klinzmann D., Schmidt W. N., Stapleton J. T. 2000; Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol 74:10055–10062 [CrossRef]
     [Google Scholar]
  49. Xing L., Huhtala M., Pietiainen V. & 7 other authors 2004; Structural and functional analysis of integrin α 2I domain interaction with echovirus 1. J Biol Chem 279:11632–11638 [CrossRef]
     [Google Scholar]
  50. Zahn A., Allain J. P. 2005; Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J Gen Virol 86:677–685 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81826-0
Loading
Hepatitis C virus interacts with human platelet glycoprotein VI
J. Gen. Virol. 87, 2243 (2006); https://doi.org/10.1099/vir.0.81826-0
/content/journal/jgv/10.1099/vir.0.81826-0
/content/journal/jgv/10.1099/vir.0.81826-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error